SILO Insider Trading Activity and SEC Form 4 Filings
SILO insider trading summary
Over the past 12 months, insiders at Silo Pharma, Inc. (SILO) reported 6 open-market purchases worth $8K by 1 insider and no sales on SEC Form 4. Net insider buying was $8K.
Latest SILO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 15, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $1K (2,500 @ $0.42) |
| Dec 15, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $1K (2,500 @ $0.41) |
| Nov 21, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $365 (1,000 @ $0.36) |
| Nov 20, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $370 (1,000 @ $0.37) |
| Nov 19, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $2K (4,500 @ $0.41) |
| Nov 18, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $3K (7,500 @ $0.40) |
| May 27, 2025 | Eric Weisblum | Chief Executive Officer | Buy | $4K (10,000 @ $0.43) |
| Dec 13, 2024 | Eric Weisblum | CEO and President | Buy | $2K (2,500 @ $0.84) |
| Nov 22, 2024 | Eric Weisblum | CEO and President | Buy | $2K (2,500 @ $0.90) |
| Nov 20, 2024 | Eric Weisblum | CEO and President | Buy | $2K (2,500 @ $0.95) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.